Detalhe da pesquisa
1.
Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration-QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers.
Clin Transl Sci
; 13(2): 325-336, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654487
2.
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma.
Hepatol Int
; 11(2): 199-208, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27909950
3.
Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies.
J Clin Oncol
; 23(23): 5281-93, 2005 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16009947
4.
Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey data, 1997-2002.
Clin Ther
; 28(7): 1044-53, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16990083
5.
Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.
J Clin Oncol
; 22(22): 4456-62, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15483017
6.
The Patient-Centered Future of Clinical Pharmacology.
Clin Pharmacol Ther
; 107(1): 72-75, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31751490
7.
Correction to Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group.
J Med Chem
; 61(7): 3237, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29589934
8.
Relationship between age, renal function and bone mineral density in the US population.
Osteoporos Int
; 14(7): 570-6, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12844211